FIELD: chemistry.
SUBSTANCE: said invention relates to a method for obtaining a compound of the formula
where R3 is a halogen, which includes the removal of protection from the compound of the formula
where the removal of protection occurs in the presence of HCl acid and where THP is tetrahydropyranyl.
EFFECT: technical result-a new method for obtaining the compound formula has been developed, which has the properties of modulating the activity of PI3-kinase and can find its application in medicine.
15 cl, 19 dwg, 6 tbl, 53 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOME CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2010 |
|
RU2582676C2 |
| CERTAIN CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2014 |
|
RU2716703C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2537549C2 |
| COMPOSITIONS AND METHODS FOR USING ESTER DERIVATIVES OF BIMATOPROST | 2012 |
|
RU2599249C2 |
| CHEMOKINE RECEPTOR MODULATORS AND USE THEREOF | 2017 |
|
RU2768827C2 |
| SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2014 |
|
RU2683793C2 |
| THERAPEUTICALLY ACTIVE DERIVATIVES OF OXAZOLINE | 2013 |
|
RU2656209C2 |
| SUBSTITUTED ISOQUINOLINES AND ISOQUINOLINONES AS Rho-KINASE INHIBITORS | 2009 |
|
RU2538588C2 |
| COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA-2-ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2013 |
|
RU2661877C2 |
